JP5408882B2 - Salivary secretion promoter - Google Patents
Salivary secretion promoter Download PDFInfo
- Publication number
- JP5408882B2 JP5408882B2 JP2008012080A JP2008012080A JP5408882B2 JP 5408882 B2 JP5408882 B2 JP 5408882B2 JP 2008012080 A JP2008012080 A JP 2008012080A JP 2008012080 A JP2008012080 A JP 2008012080A JP 5408882 B2 JP5408882 B2 JP 5408882B2
- Authority
- JP
- Japan
- Prior art keywords
- oral
- acid
- salivary secretion
- secretion
- salivary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000028327 secretion Effects 0.000 title claims description 36
- 239000002773 nucleotide Substances 0.000 claims description 22
- 125000003729 nucleotide group Chemical group 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 20
- 210000003296 saliva Anatomy 0.000 claims description 18
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 claims description 5
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 5
- 229950006790 adenosine phosphate Drugs 0.000 claims description 5
- 229930183912 Cytidylic acid Natural products 0.000 claims description 4
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 claims description 4
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims description 4
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 claims description 3
- FOGRQMPFHUHIGU-UHFFFAOYSA-N Uridylic acid Natural products OC1C(OP(O)(O)=O)C(CO)OC1N1C(=O)NC(=O)C=C1 FOGRQMPFHUHIGU-UHFFFAOYSA-N 0.000 claims description 3
- 235000013305 food Nutrition 0.000 description 12
- 210000000214 mouth Anatomy 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000013588 oral product Substances 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 description 3
- -1 Alkali metal salts Chemical class 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 3
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 235000013902 inosinic acid Nutrition 0.000 description 3
- 239000004245 inosinic acid Substances 0.000 description 3
- 229940028843 inosinic acid Drugs 0.000 description 3
- 239000002324 mouth wash Substances 0.000 description 3
- 229940051866 mouthwash Drugs 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 210000003079 salivary gland Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010065764 Mucosal infection Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 208000025157 Oral disease Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- PVBRXXAAPNGWGE-LGVAUZIVSA-L disodium 5'-guanylate Chemical compound [Na+].[Na+].C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP([O-])([O-])=O)[C@@H](O)[C@H]1O PVBRXXAAPNGWGE-LGVAUZIVSA-L 0.000 description 2
- 235000013896 disodium guanylate Nutrition 0.000 description 2
- 239000004198 disodium guanylate Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 239000004226 guanylic acid Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 208000028169 periodontal disease Diseases 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- NTQVODZUQIATFS-WAUHAFJUSA-N (2s)-2-[[(2s)-6-amino-2-[[2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-amino-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]hexanoyl]amino]-3-methylbutanoic acid Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O NTQVODZUQIATFS-WAUHAFJUSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000120 Artificial Saliva Substances 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000029301 Mastication disease Diseases 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 description 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030973 Oral discomfort Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 102100037132 Proteinase-activated receptor 2 Human genes 0.000 description 1
- 101710121435 Proteinase-activated receptor 2 Proteins 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000021386 Sjogren Syndrome Diseases 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000009045 body homeostasis Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229940042125 oral ointment Drugs 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000002223 uridyl group Chemical group 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cosmetics (AREA)
Description
本発明は、口腔内の乾燥を癒す唾液分泌促進剤等に関する。 The present invention relates to a salivary secretion promoter and the like that heals dryness in the oral cavity.
唾液腺は、咀嚼、消化、味覚および正常な粘膜の維持に必要な唾液分泌、並びにホルモンや成長因子の産生等の機能を有し、体の恒常性の維持に重要な役割を担っている。 The salivary glands have functions such as salivation necessary for mastication, digestion, taste and maintenance of normal mucous membranes, and production of hormones and growth factors, and play an important role in maintaining body homeostasis.
唾液分泌が低下する原因には、主としてシェーグレン症候群、糖尿病、肝硬変、腎疾患等の内科疾患、加齢による分泌機能低下、エイズ、唾液腺の器質的変化を起こす各種疾患、癌治療における放射線照射および各種薬物による副作用等が挙げられる。 Causes of decreased salivary secretion are mainly internal diseases such as Sjogren's syndrome, diabetes, liver cirrhosis, and kidney disease, decreased secretory function due to aging, various diseases that cause organic changes in salivary glands, radiation in cancer treatment and various Examples include side effects caused by drugs.
唾液分泌が低下することによって生ずる口腔内乾燥症により、口臭発生、口腔内不快感および感染症または炎症の発生等の症状が現れる。特に、唾液腺の機能が低下した老人に、副作用として唾液分泌抑制作用を有する薬物を投与する際には注意が必要である。 Symptoms such as the generation of bad breath, oral discomfort and the occurrence of infections or inflammation appear due to xerostomia caused by a decrease in saliva secretion. In particular, care should be taken when administering a drug having a salivary secretion-inhibiting action as a side effect to an elderly person whose salivary gland function has declined.
また、口腔内の乾燥は日常生活でも経験され、べとべとした不快感、会話の困難さ、口臭の発生等を伴う。さらに病的になると、口腔内菌叢の変化から、う蝕、歯周疾患、粘膜の感染症等、口腔機能の不全(咀嚼障害、嚥下困難、味覚異常等)を生ずる。 In addition, drying in the oral cavity is also experienced in daily life, and is accompanied by sticky discomfort, difficulty in conversation, and the generation of bad breath. Furthermore, when pathological, the oral microbiota changes, resulting in oral function defects (mastication disorder, difficulty swallowing, abnormal taste, etc.) such as caries, periodontal disease, mucosal infection, and the like.
従って、唾液の分泌を促進して口腔内を潤すことは、口腔を爽快に保ち、口腔疾患を予防する上で重要である。 Therefore, promoting saliva secretion and moisturizing the oral cavity is important for keeping the oral cavity refreshing and preventing oral diseases.
そこで、口腔内を爽快に保ち、口腔内を潤すことで口腔疾患を予防するために、例えば、保湿剤であるヒアルロン酸の利用が提案されている。しかし、ヒアルロン酸には保湿作用はあるものの、積極的に唾液分泌を促進する作用は認められない。 In order to prevent oral diseases by keeping the oral cavity refreshing and moisturizing the oral cavity, for example, the use of hyaluronic acid as a moisturizing agent has been proposed. However, although hyaluronic acid has a moisturizing action, it does not positively promote salivary secretion.
一方、積極的に唾液の分泌を促進して口腔内を潤すことも提案され、その手段として味覚的、ないしは嗅覚的に刺激を与える方法が知られており、例えば有機酸を唾液分泌促進剤として使用する方法や、グレープフルーツ調香料等を用いる方法が提案されている。 On the other hand, it has also been proposed to actively promote the secretion of saliva to moisturize the oral cavity, and as a means there is known a method of giving a taste or olfactory stimulus, for example, using an organic acid as a saliva secretion promoter The method of using and the method of using a grapefruit flavoring etc. are proposed.
しかしながら、酸味等の味覚刺激や嗅覚刺激成分による唾液分泌促進効果は、刺激を受けた直後の短時間に集中していることから、味覚刺激、嗅覚刺激の消失とともに効果が消失し、効果の持続性に欠けるという問題点を有していた。また、とくに味覚刺激を用いた方法では、有機酸により歯を傷める危険性から使用について制約が生じ、さらには促進剤自身が強い味や匂いを呈することから食品・口腔内用品としての用途が制限されていた。 However, the salivary secretion-promoting effect by taste stimuli such as sourness and olfactory stimuli concentrates in a short period of time immediately after being stimulated, so the effect disappears with the disappearance of taste and olfactory stimuli, and the effect continues It had the problem of lacking in nature. In particular, in the method using taste stimuli, there are restrictions on the use due to the risk of damaging teeth by organic acids, and further, the accelerator itself has a strong taste and smell, limiting the use as food and oral products It had been.
他にも、有機酸及び羅漢果またはその抽出物を含有する唾液分泌促進剤や、コーラノキ種子末またはその抽出成分及び有機酸を含有する唾液分泌促進剤が提案されているが、これらの唾液分泌促進剤についても有機酸を併用することが必須または推奨されており、上記と同様の問題が生じうる。 In addition, salivary secretion promoters containing organic acids and Rakan fruit or extracts thereof, and saliva secretion promoters containing cola seed powder or its extract components and organic acids have been proposed. It is essential or recommended to use an organic acid in combination with the agent, and the same problem as described above may occur.
さらに、ムスカリン受容体を標的とした薬物や、PAR−2を標的とした薬物等の唾液分泌促進物質が報告されているが、これらの薬物には副作用の懸念がある。 In addition, salivary secretion-promoting substances such as drugs targeting muscarinic receptors and drugs targeting PAR-2 have been reported, but these drugs have a side effect.
一方、ヌクレオチドは食品や口腔用品に広く含まれ、あるいは添加されている物質であり、安全に利用できることが知られている。また、例えば特許文献1に示されるように、イノシン酸などのヌクレオチドの使用量を限定すれば、味覚に強い影響を及ぼすものではないことも公知である。しかしながら、従来、ヌクレオチドを唾液分泌促進のために使用した例は知られていない。 On the other hand, nucleotides are substances that are widely contained or added to foods and oral products and are known to be safe to use. It is also known that, for example, as disclosed in Patent Document 1, if the amount of nucleotides such as inosinic acid is limited, it does not strongly affect the taste. However, there has been no known example in which nucleotides are used for promoting salivary secretion.
本発明は、従来の唾液分泌促進方法の問題点を解決するために、口腔内に適用しても味覚を損なうことなく唾液分泌を促し、しかも安全性に優れた唾液分泌促進剤等を提供することを目的とする。 In order to solve the problems of the conventional saliva secretion promoting method, the present invention provides a saliva secretion promoting agent that promotes saliva secretion without impairing the taste even when applied to the oral cavity and that is excellent in safety. For the purpose.
本発明者は、上記目的を達成するため鋭意検討を行った結果、イノシン酸を除くヌクレオチドに優れた唾液分泌促進活性があることを知見し、これを発展させ、本発明をなすに至ったものである。すなわち、本発明は以下の発明を包含する。 As a result of intensive studies to achieve the above object, the present inventor has found that nucleotides other than inosinic acid have an excellent salivary secretion promoting activity, and have developed this to achieve the present invention. It is. That is, the present invention includes the following inventions.
(1)アデニル酸、グアニル酸、シチジル酸およびウリジル酸からなる群から選ばれた少なくとも1種のヌクレオチドを含有することを特徴とする唾液分泌促進剤。 (1) A salivary secretion promoter characterized by containing at least one nucleotide selected from the group consisting of adenylic acid, guanylic acid, cytidylic acid and uridylic acid.
本発明における唾液分泌促進剤は、味覚に対する問題がほとんど無いため、口腔用組成物、食品組成物に制限なく配合できる。また、本発明の唾液分泌促進剤は生体内物質や食品添加物としても知られており、安全性が高く、口腔用品、食品の素材として最適である。 Since the salivary secretion promoter in the present invention has almost no problem with taste, it can be incorporated into oral compositions and food compositions without limitation. Moreover, the salivary secretion promoter of the present invention is also known as an in vivo substance or food additive, has high safety, and is optimal as a material for oral products and foods.
さらに、本発明の方法あるいは唾液分泌促進剤または飲食品を用いれば、重度な口腔乾燥症に対しても口腔粘膜に潤いを与えることができ、結果として口腔内の乾燥に伴うべとべとした不快感、会話の困難さ、口臭の発生等が速やかに解消される。したがって、う蝕、歯周疾患、粘膜の感染症等、口腔機能の不全をも予防することができることが期待できる。 Furthermore, if the method of the present invention or the salivary secretion promoter or food or drink is used, it can moisturize the oral mucosa even for severe xerostomia, resulting in sticky discomfort associated with dry mouth, The difficulty of conversation and the occurrence of bad breath are quickly resolved. Therefore, it is expected that oral function defects such as caries, periodontal disease, mucosal infection, etc. can be prevented.
本発明で使用するヌクレオチドとしては、食品・口腔用品等に利用可能なものを用いればよく、例えばアデニル酸、シチジル酸、ウリジル酸またはグアニル酸からなる群から選択された1種または2種以上を使用することができる。ただし、イノシン酸は、唾液分泌促進効果が極めて低いため、使用するヌクレオチドからは除外される。 The nucleotide used in the present invention may be any nucleotide that can be used in foods and oral products, for example, one or more selected from the group consisting of adenylic acid, cytidylic acid, uridylic acid or guanylic acid. Can be used. However, inosinic acid is excluded from nucleotides to be used because it has a very low salivary secretion promoting effect.
また、ヌクレオチドを複数混合したものとしては、単品同士を混合したもののほか、RNAを酵素分解して得られるヌクレオチド混合物、あるいはその混合物をさらに分画、塩析、沈殿等の簡単な精製処理を施したものも本発明のヌクレオチドとして使用することができる。 In addition to a mixture of single nucleotides, a mixture of single nucleotides, a nucleotide mixture obtained by enzymatic degradation of RNA, or a mixture thereof is further subjected to simple purification treatments such as fractionation, salting out, and precipitation. These can also be used as the nucleotides of the present invention.
これらのヌクレオチドは、遊離の形態だけでなく、塩の形態であってもよく、ナトリウム塩、カリウム塩などのアルカリ金属塩、カルシウム塩などのアルカリ土類金属塩等も本発明のヌクレオチドとして利用し得る。 These nucleotides may be in the form of salts as well as free forms. Alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts and the like are also used as the nucleotides of the present invention. obtain.
本発明の唾液分泌促進剤(ヌクレオチド)を、口腔用組成物、食品組成物に使用する場合、全体に対するヌクレオチドの配合量は、好ましくは0.05〜10%(質量%(w/v)、以下同様)、とくに好ましくは 0.1〜5%とすることができる。配合量が少なすぎると良好な効果が発揮されないおそれがあり、また配合量が10%を超えるとヌクレオチドそのものの呈味が強くなり過ぎる場合がある。 When the salivary secretion promoter (nucleotide) of the present invention is used in an oral composition or food composition, the amount of nucleotides based on the total is preferably 0.05 to 10% (mass% (w / v), The same shall apply hereinafter), particularly preferably 0.1 to 5%. If the blending amount is too small, good effects may not be exhibited, and if the blending amount exceeds 10%, the taste of the nucleotide itself may be too strong.
この場合、本発明の唾液分泌促進剤の投与量は唾液分泌促進有効量であり、適宜選定されるが、一回の投与量は0.005〜1g/成人1名(体重60kg)の範囲であることが好ましい。 In this case, the dosage of the salivary secretion-promoting agent of the present invention is a salivary secretion-promoting effective amount, and is selected as appropriate. The single dose is in the range of 0.005 to 1 g / one adult (weight 60 kg). Preferably there is.
本発明の唾液分泌促進剤は、口腔用組成物(歯磨類、洗口剤、咀嚼錠、口腔用軟膏、うがい用錠剤、トローチ、人工唾液、義歯安定剤、給水吸引機能付き口腔ケアシステム用溶液等)、食品組成物(嚥下補助剤、キャンディ、チューインガム、ドリンク剤、グミ等)に配合でき、その種類、剤型に応じ、上記必須成分に加えて任意成分としてその他の公知の添加剤を配合することができる。 The salivary secretion promoter of the present invention is a composition for oral cavity (a dentifrice, mouthwash, chewing tablet, oral ointment, gargle tablet, troche, artificial saliva, denture stabilizer, solution for oral care system with water supply suction function) Etc.), food compositions (swallowing aids, candy, chewing gum, drinks, gummi, etc.) and other known additives as optional ingredients in addition to the above essential ingredients depending on the type and dosage form can do.
例えば、洗口液等の液状口腔用組成物及びペースト状口腔用組成物の場合、本発明の唾液分泌促進剤の他に、粘稠剤、粘結剤、界面活性剤、甘味剤、防腐剤、着色剤、香料、各種有効成分等を配合し得る。これら成分を水と混合して製造することができる。また、歯磨組成物の場合であれば研磨剤を、液状組成物である場合にはエタノール等の非毒性溶剤を配合することができる。 For example, in the case of a liquid oral composition such as a mouthwash and a paste-like oral composition, in addition to the saliva secretion promoter of the present invention, a thickener, a binder, a surfactant, a sweetener, a preservative , Coloring agents, fragrances, various active ingredients and the like can be blended. These components can be produced by mixing with water. In the case of a dentifrice composition, an abrasive can be blended, and in the case of a liquid composition, a non-toxic solvent such as ethanol can be blended.
さらに、口腔用組成物を、錠剤、トローチ剤等の固形製剤として調製する場合は、非毒性の賦形剤、結合剤、崩壊剤、滑沢剤、さらに上述した界面活性剤、甘味剤、香料等を配合し得る。 Further, when the oral composition is prepared as a solid preparation such as a tablet or troche, non-toxic excipients, binders, disintegrants, lubricants, and the above-mentioned surfactants, sweeteners, and fragrances. Etc. may be blended.
一方、食品組成物においても、その食品の種類に応じた食品素材が用いられる。例えば、チューインガムの場合であれば、砂糖等の糖類、ガムベース等を含有するものとし得、キャンディ等の飴菓子の場合であれば、水飴、砂糖等を含有するものとし得る。 On the other hand, also in the food composition, a food material corresponding to the type of the food is used. For example, in the case of chewing gum, it may contain sugars such as sugar, gum base and the like, and in the case of candy sweets such as candy, it may contain chickenpox, sugar and the like.
以下、実施例を示し、本発明を具体的に説明するが、本発明がこれに限定されないことは明らかである。 Hereinafter, the present invention will be described in detail with reference to examples, but it is clear that the present invention is not limited thereto.
実施例1:ヌクレオチドによる唾液分泌促進効果
唾液分泌量の測定は既知の方法(Jpn.J.Pharmacol.78,373−380,1998)に準じて行った。ICR系雄性マウス(各群10匹、39〜42週齢、体重43〜57g)をペントバルビタールナトリウムで麻酔し(20mg/kg,ip+60mg/kg,s.c.)、投与する物質の種類に応じて5つの群に分けた。
Example 1: Salivary secretion promoting effect by nucleotide Salivary secretion was measured according to a known method (Jpn. J. Pharmacol. 78, 373-380, 1998). ICR male mice (10 mice in each group, 39-42 weeks old, body weight 43-57 g) are anesthetized with sodium pentobarbital (20 mg / kg, ip + 60 mg / kg, sc), depending on the type of substance administered Divided into 5 groups.
マウスの口腔内にあらかじめ重量を調整(25mg±10%)・測定しておいたボール状の脱脂綿を挿入し、直ちに、4つの群に対してそれぞれアデニル酸、グアニル酸二ナトリウム、シチジル酸、ウリジル酸二ナトリウムの10%水溶液を100μl滴下した。対照群には蒸留水100μlを滴下した。 The ball-shaped absorbent cotton whose weight was adjusted (25mg ± 10%) and measured in advance in the mouse's mouth was inserted, and immediately adenylic acid, disodium guanylate, cytidylic acid, uridyl for each of the four groups 100 μl of a 10% aqueous solution of disodium acid was added dropwise. 100 μl of distilled water was added dropwise to the control group.
10分後に脱脂綿を回収し、直ちに新たなボール状脱脂綿(25mg±10%)を挿入した。20分後、その脱脂綿を回収し、直ちに重量を測定し、挿入前と挿入後の重量差を唾液分泌量とした。 Absorbent cotton was collected after 10 minutes, and new ball-shaped absorbent cotton (25 mg ± 10%) was immediately inserted. After 20 minutes, the absorbent cotton was collected and immediately weighed, and the difference in weight before and after insertion was defined as the saliva secretion amount.
測定の結果、表1に示す4種のヌクレオチドは著しい唾液分泌増加作用を示すことが確認された。尚、表中のデータは以下の式にて各種ヌクレオチドの投与による唾液分泌増加率を算出後、増加率を%で表したものである。
増加率(%)=(各種ヌクレオチド投与群の唾液分泌量/対照群の唾液分泌量)×100−100
As a result of the measurement, it was confirmed that the four types of nucleotides shown in Table 1 showed a remarkable salivary secretion increasing action. The data in the table represents the increase rate in% after calculating the increase rate of saliva secretion by administration of various nucleotides by the following formula.
Increase rate (%) = (saliva secretion amount of various nucleotide administration groups / saliva secretion amount of control group) × 100-100
実施例2:各種組成物例
(1)唾液分泌促進剤を含む口腔用品
以下の組成に従って、本発明に記載の唾液分泌促進剤を含む洗口剤を作製した。
水分80.49%、エタノール8%、グリセリン8%、ツウィーン−20 1.5%、クエン酸1%、パラベン0.01%、アデニル酸1%
Example 2: Various composition examples (1) Oral products containing a saliva secretion promoter A mouthwash containing the saliva secretion promoter described in the present invention was prepared according to the following composition.
Water 80.49%, ethanol 8%, glycerin 8%, Tween-20 1.5%, citric acid 1%, paraben 0.01%, adenylic acid 1%
(2)唾液分泌促進剤を含む食品
以下の組成に従って、本発明に記載の唾液分泌促進剤を含むキャンディ及びチューインガムを作製した。
(2) Food containing saliva secretion promoter A candy and chewing gum containing the saliva secretion promoter according to the present invention were prepared according to the following composition.
(キャンディ)
キシリトール88.5%、ソルビトール10%、香料0.3%、スクラロース0.1%、着色剤0.1%、グアニル酸二ナトリウム1%
(candy)
Xylitol 88.5%, Sorbitol 10%, Fragrance 0.3%, Sucralose 0.1%, Colorant 0.1%, Disodium guanylate 1%
(チューインガム)
ガムベース25%、キシリトール40%、パラチニット30%、マルチトールシロップ2.5%、軟化剤0.9%、アスパルテーム0.1%、香料0.5%、ウリジル酸二ナトリウム1%
(Chewing gum)
25% gum base, 40% xylitol, 30% palatinit, 2.5% maltitol syrup, 0.9% softener, 0.1% aspartame, 0.5% fragrance, 1% disodium uridylate
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008012080A JP5408882B2 (en) | 2008-01-23 | 2008-01-23 | Salivary secretion promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008012080A JP5408882B2 (en) | 2008-01-23 | 2008-01-23 | Salivary secretion promoter |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013139430A Division JP2013224322A (en) | 2013-07-03 | 2013-07-03 | Salivator |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009173564A JP2009173564A (en) | 2009-08-06 |
JP5408882B2 true JP5408882B2 (en) | 2014-02-05 |
Family
ID=41029075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008012080A Active JP5408882B2 (en) | 2008-01-23 | 2008-01-23 | Salivary secretion promoter |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5408882B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102580098B (en) * | 2011-01-05 | 2015-11-25 | 艾博生物医药(杭州)有限公司 | A kind of reagent of exciting salivary secretion |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0279986A (en) * | 1988-08-19 | 1990-03-20 | Rinjiro Saruno | Production of red aspergillus coloring matter |
JP3389719B2 (en) * | 1994-12-22 | 2003-03-24 | ライオン株式会社 | Oral composition |
JP3580900B2 (en) * | 1995-04-20 | 2004-10-27 | ホクレン農業協同組合連合会 | Food and feed containing, as an active ingredient, a composition mainly comprising a sugar containing an α-glucosidase inhibitor |
WO2000050024A2 (en) * | 1999-02-26 | 2000-08-31 | Inspire Pharmaceuticals, Inc. | Method of promoting mucosal hydration with certain uridine, adenine and cytidine diphosphates and analogs thereof |
JP2000319185A (en) * | 1999-03-10 | 2000-11-21 | Yamasa Shoyu Co Ltd | Lipid metabolism regulation agent and its use |
JP4010390B2 (en) * | 1999-09-20 | 2007-11-21 | 明治乳業株式会社 | Immunostimulatory composition |
CA2395108A1 (en) * | 1999-12-22 | 2001-06-28 | Inspire Pharmaceuticals, Inc. | Method of treating gastrointestinal tract disease with purinergic receptor agonists |
JP2002000184A (en) * | 2000-06-21 | 2002-01-08 | Kao Corp | A throat care candy |
JP2002173425A (en) * | 2000-12-07 | 2002-06-21 | Kao Corp | Throat care agent |
JP2002191298A (en) * | 2000-12-27 | 2002-07-09 | Kohjin Co Ltd | Improving agent for retort odor of retort food and retort food containing improving agent |
CN1771046A (en) * | 2003-04-11 | 2006-05-10 | 协和发酵工业株式会社 | Preventive or therapeutic agent for arthritis |
JP2005052041A (en) * | 2003-08-01 | 2005-03-03 | Hosoda Shc:Kk | Seasoning composition |
EP1734836B1 (en) * | 2004-04-06 | 2016-12-07 | Givaudan S.A. | Taste improving substances |
JP4656859B2 (en) * | 2004-05-19 | 2011-03-23 | 明治飼糧株式会社 | Oxidative stress inhibitor |
EP1778239B1 (en) * | 2004-07-28 | 2013-08-21 | Can-Fite Biopharma Ltd. | Adenosine a3 receptor agonists for the treatment of dry eye disorders including sjogren's syndrome |
US8067537B2 (en) * | 2004-09-03 | 2011-11-29 | Kyowa Hakko Bio Co., Ltd. | Composition and method for treatment of stomatitis |
JP4124260B2 (en) * | 2004-09-17 | 2008-07-23 | 味の素株式会社 | Functional gastrointestinal disorder preventive / ameliorating agent and food |
JP5546089B2 (en) * | 2004-10-04 | 2014-07-09 | 大正製薬株式会社 | Composition containing zinc compound |
JP4559344B2 (en) * | 2004-11-12 | 2010-10-06 | 花王株式会社 | Liquid seasoning |
WO2007108071A1 (en) * | 2006-03-17 | 2007-09-27 | Pharma Foods International Co., Ltd. | Antistress composition and food and drink containing the same |
-
2008
- 2008-01-23 JP JP2008012080A patent/JP5408882B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009173564A (en) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1882353B (en) | Sialagogue, and oral composition and food composition containing the same | |
JP4111916B2 (en) | Composition for alleviating xerostomia and treating related diseases | |
JP2005512992A (en) | Anti-calculus and anti-plaque solid oral composition | |
US7087219B2 (en) | Toothpaste containing anticancer agents | |
JP6795316B2 (en) | Oral care composition containing L-aspartic acid or a salt thereof, and nicotinamide. | |
JP2002179541A (en) | Composition for oral cavity containing cationic disinfectant | |
JP5754711B2 (en) | Oral hygiene composition effective in promoting salivation and oral care product | |
KR20130027751A (en) | Oral composition containing clove oil or eugenol | |
JP5408882B2 (en) | Salivary secretion promoter | |
JP2021017450A (en) | Compositions and methods for treating oral cavity | |
JP4909809B2 (en) | Artificial saliva | |
KR20190045623A (en) | Oral compositions | |
KR102700606B1 (en) | Composition for prevention or treatment of oral disease comprising icaritin | |
JP2015096473A (en) | Saliva secretion promoter and oral composition comprising the same | |
JP2014139163A (en) | Body fluid secretion promoter | |
JP3690442B2 (en) | Salivary secretion promoter, oral composition and denture stabilizer | |
US20060246016A1 (en) | Toothpaste containing anticancer agents | |
JP2013224322A (en) | Salivator | |
JP6030069B2 (en) | Oral cleaning composition for prevention and / or treatment of periodontal disease | |
JP6472722B2 (en) | Salivary secretagogue for oral administration | |
JP4804420B2 (en) | Artificial saliva | |
KR20090079366A (en) | Toothpaste composition containing menthol and sugar alcohols | |
KR102665309B1 (en) | Composition for prevention or treatment of oral disease comprising Cordycepin | |
WO2016195089A1 (en) | Salivation promoter, xerostomia inhibitor, oral cavity moisturizer, and compositions | |
JP2007291117A (en) | Artificial saliva |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20100506 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20121001 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130129 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130508 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130703 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20131105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131105 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5408882 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |